Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Tag: Richard Lowenthal
FDA Panel Supports Approval of neffy® Epinephrine Nasal Spray
Dave Bloom
-
2023/05/12
The first needle-free emergency epinephrine alternative is on the verge of FDA approval.
FDA Schedules Review of neffy®, an Intranasal Alternative to Epinephrine Auto-Injectors
Dave Bloom
-
2023/03/28
Meeting signals the FDA believes neffy has potential for approval given data gleaned from clinical trials.
FDA Accepts New Drug Application for Nasal Epinephrine Spray Treatment for...
Dave Bloom
-
2022/10/21
If approved, acceptance targeted for mid-2023.
CEO Expects Approval and Launch of Intranasal Emergency Epinephrine Spray by...
Dave Bloom
-
2022/03/02
The market for epinephrine delivery may expand to include non-needle alternatives next year.
Emergency Epinephrine Nasal Spray Takes Final Step Toward Approval in EU
Dave Bloom
-
2020/11/30
A needle-free option for administration of epinephrine is on the horizon.
ARS Pharmaceuticals Announces New Patent on ARS-1 (Epinephrine Nasal Spray)
News Wire ~ 3rd Party Press Release
-
2020/07/13
Intranasal delivery of emergency epinephrine takes another step closer to becoming a reality.
ARS to Present Data from Intranasal Epinephrine (ARS-1) Studies at AAAAI...
News Wire ~ 3rd Party Press Release
-
2020/03/02
Neffy™ (formally ARS-1) was fast-tracked by the FDA in 2019 as an intranasal alternative to epinephrine auto-injectors.
FDA Fast Tracks ARS-1 Intranasal Epinephrine Spray
News Wire ~ 3rd Party Press Release
-
2019/02/19
Company provides a novel means of administering emergency epinephrine.